Semaglutide improves outcomes for obese patients with common skin condition, new study shows
A pioneering study, presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, demonstrates the significant potential of semaglutide in treating hidradenitis suppurative (HS), a common and chronic skin condition, in people with obesity.
Ozempic is bridging the political divide
The health benefits of blockbuster weight loss drugs are bridging the stark political divide in the United States. Read more…
Ozempic linked to lower opioid overdose rate in those with diabetes, study shows
“The preliminary findings from this study point to the possibility that GLP-1 medications may have value in helping to prevent opioid overdoses.”
Tirzepatide Leads to Long-Term Glucose Control
While several factors predict sustained glycemic control, predictors of sustained weight control with tirzepatide appear elusive, though women show greater weight reduction in general. Medscape Medical News
Screening Familial Risk for Hereditary Breast and Ovarian Cancer
This cross-sectional study examines whether patients meeting the family history criteria for genetic testing for breast cancer can be identified through electronic health records.
Semaglutide and Opioid Overdose Risk in Patients With T2D and OUD
This cohort study uses emulation target trial methods to evaluate whether semaglutide is associated with lower rates of opioid overdose among patients with type 2 diabetes (T2D) and opioid use disorder (OUD).
Semaglutide reduces heart failure events in patients with preserved ejection fraction
1. Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant difference was observed between groups for cardiovascular death alone. Evidence Rating Level: 1 (Excellent) Study Rundown: Heart failure with preserved ejection fraction (HFpEF) is the most common form of heart failure, affecting patients with obesity,
The post Semaglutide reduces heart failure events in patients with preserved ejection fraction first appeared on 2 Minute Medicine. Source: 2 Minute Medicine
‘Stop Ripping Us Off’: Senate Goes After Ozempic-Maker Over Pricing
(MedPage Today) — Sen. Bernie Sanders (I-Vt.) on Tuesday challenged Novo Nordisk’s CEO to lower the cost of semaglutide (Ozempic, Wegovy) during a Senate Health, Education, Labor and Pensions (HELP) Committee hearing.
Sanders, the chair of the…
Could GLP1RA drugs lower high iron levels?
Increased iron levels can be dangerous for those with type 2 diabetes.
GLP1RA could drugs lower high iron levels, study finds
GLP1RA agonists have been increasing in popularity for treating obesity and type 2 diabetes.